Inside Mount Sinai
In this issue:
- James Ferrara, MD, is leading a world-class research program at Mount Sinai to treat graft-versus-host disease, a serious complication of bone marrow transplantation.
- Ron Shapiro, MD, joins Mount Sinai’s Recanati Miller Transplantation Institute as the new Surgical Director of the Kidney and Pancreas Transplant Program.
- Mount Sinai researchers, under Adolfo Garcia-Sastre, PhD, have identified 53 FDA-approved drugs that may help fight the Ebola virus.
- The Mount Sinai Health System has partnered with Empire BlueCross BlueShield to manage all aspects of care for Empire’s 48,000 commercial and Medicare members.
- Kristjan Ragnarsson, MD, has received a lifetime achievement award from the American Academy of Physical Medicine and Rehabilitation.
- Mount Sinai Health System nurses were recognized for extraordinary achievements in a Tribute to Nurses, the special New York Times Magazine advertising section; STRIVE has named Mount Sinai an Outstanding Partner of the Year for its efforts in hiring East Harlem residents; and Will Parker, a security worker at Mount Sinai Beth Israel, is also a singer and composer who performs at fine hotels in New York City. On February 2, he will perform on the Mount Sinai Beth Israel campus.